{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "Treating lung cancer using human monoclonal antibodies to protein tyrosine kinase 7 (PTK7)", "item": "https://www.patentleaderboard.com/patent/9505845"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treating lung cancer using human monoclonal antibodies to protein tyrosine kinase 7 (PTK7)

Treating lung cancer using human monoclonal antibodies to protein tyrosine kinase 7 (PTK7)

US Patent 9505845 · Granted Nov 29, 2016

Estimated economic value: $608,762,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Matrix metalloprotease-cleavable and serine protease-cleavable substrates and me2025
Genetically engineered T cells having improved persistence in culture2025
T-cells expressing anti-LIV1 chimeric antigen receptor2025
Methods and compositions for treating cancer2025
Anti-PTK7 immune cell cancer therapy2024
Anti-CD27 antibodies and uses thereof2024
Methods and compositions for treating angiopoietin-like 3 (ANGPTL3) related cond2024
Masked chimeric antigen receptor specific to tyrosine-protein kinase like 7 (PTK2024
Anti-CD166 antibodies, activatable anti-CD166 antibodies, and methods of use the2023
Methods and compositions for treating cancer2023
Materials and methods for engineering cells and uses thereof in immuno-oncology2023
Matrix metalloprotease-cleavable and serine protease-cleavable substrates and me2023